Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41

3 Segmentation of Europe Market by Offering 45
3.1 Market Overview by Offering 45
3.2 Products 47
3.3.1 Probiotics 48
3.3.2 Prebiotics 49
3.3.3 Vitamins & Supplements 50
3.3 Testing Services 51
3.3.1 Nutrigenomics Clinical Testing 52
3.3.2 Nutrigenomics Research Testing 53

4 Segmentation of Europe Market by Test Technology 54
4.1 Market Overview by Test Technology 54
4.2 Next-generation Sequencing 56
4.3 Real-time PCR 57
4.4 DNA Microarray 58
4.5 Sanger Sequencing 59

5 Segmentation of Europe Market by Test Sample 60
5.1 Market Overview by Test Sample 60
5.2 Buccal Swab Sample 62
5.3 Saliva Sample 63
5.4 Blood Sample 64
5.5 Other Samples 65

6 Segmentation of Europe Market by Application 66
6.1 Market Overview by Application 66
6.2 Women’s Health 68
6.3 Metabolic Disorders 69
6.4 Immune Health 70
6.5 Cancer Research 71
6.6 Cardiovascular Diseases 72
6.7 Diabetes 73
6.8 Other Applications 74

7 Segmentation of Europe Market by End User 75
7.1 Market Overview by End User 75
7.2 Hospitals 77
7.3 Nutrition Clinics 78
7.4 Diagnostics Laboratories 79
7.5 Other End Users 80

8 European Market 2021-2031 by Country 81
8.1 Overview of European Market 81
8.2 Germany 84
8.3 U.K. 86
8.4 France 88
8.5 Spain 90
8.6 Italy 92
8.7 Netherlands 94
8.8 Rest of European Market 96

9 Competitive Landscape 98
9.1 Overview of Key Vendors 98
9.2 New Product Launch, Partnership, Investment, and M&A 101
9.3 Company Profiles 102
BASF SE 102
BioGaia 104
Cell Logic 105
Cura Integrative Medicine 106
DNAfit 107
DuPont de Nemours, Inc. 108
Garden of Life, LLC 109
GeneOmbio 110
Genova Diagnostics, Inc. 111
GX Sciences, Inc. 112
Ingredion Incorporated 113
Jarrow Formulas Inc. 114
Koninklijke DSM N.V. 115
MedGenome 116
Metagenics, Inc. 117
Nutrigenomix Inc. 118
Unilever Group 119
XCODE Life 120
Yakult Honsha Co., Ltd. 121
RELATED REPORTS 122



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Europe Nutrigenomics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Europe Nutrigenomics Market 26
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million 29
Figure 8. Leading Causes of Death in the World, 2019-2020, million 31
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 32
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 32
Figure 11. Primary Restraints and Impact Factors of Europe Nutrigenomics Market 34
Figure 12. Investment Opportunity Analysis 38
Figure 13. Porter’s Fiver Forces Analysis of Europe Nutrigenomics Market 41
Figure 14. Breakdown of Europe Nutrigenomics Market by Offering, 2021-2031, % of Revenue 46
Figure 15. Europe Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 46
Figure 16. Europe Nutrigenomics Market by Offering: Products, 2021-2031, $ mn 47
Figure 17. Europe Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn 48
Figure 18. Europe Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn 49
Figure 19. Europe Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn 50
Figure 20. Europe Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn 51
Figure 21. Europe Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn 52
Figure 22. Europe Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn 53
Figure 23. Breakdown of Europe Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue 55
Figure 24. Europe Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%) 55
Figure 25. Europe Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn 56
Figure 26. Europe Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn 57
Figure 27. Europe Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn 58
Figure 28. Europe Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn 59
Figure 29. Breakdown of Europe Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue 61
Figure 30. Europe Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%) 61
Figure 31. Europe Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn 62
Figure 32. Europe Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn 63
Figure 33. Europe Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn 64
Figure 34. Europe Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn 65
Figure 35. Breakdown of Europe Nutrigenomics Market by Application, 2021-2031, % of Revenue 67
Figure 36. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 67
Figure 37. Europe Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn 68
Figure 38. Europe Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn 69
Figure 39. Europe Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn 70
Figure 40. Europe Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn 71
Figure 41. Europe Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn 72
Figure 42. Europe Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn 73
Figure 43. Europe Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn 74
Figure 44. Breakdown of Europe Nutrigenomics Market by End User, 2021-2031, % of Revenue 76
Figure 45. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 76
Figure 46. Europe Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn 77
Figure 47. Europe Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn 78
Figure 48. Europe Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn 79
Figure 49. Europe Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn 80
Figure 50. Breakdown of European Nutrigenomics Market by Country, 2021 and 2031, % of Revenue 82
Figure 51. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 83
Figure 52. Nutrigenomics Market in Germany, 2021-2031, $ mn 84
Figure 53. Nutrigenomics Market in U.K., 2021-2031, $ mn 86
Figure 54. Nutrigenomics Market in France, 2021-2031, $ mn 88
Figure 55. Nutrigenomics Market in Spain, 2021-2031, $ mn 90
Figure 56. Nutrigenomics Market in Italy, 2021-2031, $ mn 92
Figure 57. Nutrigenomics Market in Netherlands, 2021-2031, $ mn 94
Figure 58. Nutrigenomics Market in Rest of Europe, 2021-2031, $ mn 96
Figure 59. Growth Stage of Europe Nutrigenomics Industry over the Forecast Period 98

List of Tables

List of Tables:

Table 1. Snapshot of Europe Nutrigenomics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 33
Table 5. Main Product Trends and Market Opportunities in Europe Nutrigenomics Market 37
Table 6. Europe Nutrigenomics Market by Offering, 2021-2031, $ mn 45
Table 7. Europe Nutrigenomics Market: Products by Type, 2021-2031, $ mn 47
Table 8. Europe Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn 51
Table 9. Europe Nutrigenomics Market by Test Technology, 2021-2031, $ mn 54
Table 10. Europe Nutrigenomics Market by Test Sample, 2021-2031, $ mn 60
Table 11. Europe Nutrigenomics Market by Application, 2021-2031, $ mn 66
Table 12. Europe Nutrigenomics Market by End User, 2021-2031, $ mn 75
Table 13. Europe Nutrigenomics Market by Country, 2021-2031, $ mn 83
Table 14. Germany Nutrigenomics Market by Offering, 2021-2031, $ mn 85
Table 15. Germany Nutrigenomics Market by Application, 2021-2031, $ mn 85
Table 16. Germany Nutrigenomics Market by End User, 2021-2031, $ mn 85
Table 17. U.K. Nutrigenomics Market by Offering, 2021-2031, $ mn 87
Table 18. U.K. Nutrigenomics Market by Application, 2021-2031, $ mn 87
Table 19. U.K. Nutrigenomics Market by End User, 2021-2031, $ mn 87
Table 20. France Nutrigenomics Market by Offering, 2021-2031, $ mn 89
Table 21. France Nutrigenomics Market by Application, 2021-2031, $ mn 89
Table 22. France Nutrigenomics Market by End User, 2021-2031, $ mn 89
Table 23. Spain Nutrigenomics Market by Offering, 2021-2031, $ mn 91
Table 24. Spain Nutrigenomics Market by Application, 2021-2031, $ mn 91
Table 25. Spain Nutrigenomics Market by End User, 2021-2031, $ mn 91
Table 26. Italy Nutrigenomics Market by Offering, 2021-2031, $ mn 93
Table 27. Italy Nutrigenomics Market by Application, 2021-2031, $ mn 93
Table 28. Italy Nutrigenomics Market by End User, 2021-2031, $ mn 93
Table 29. Netherlands Nutrigenomics Market by Offering, 2021-2031, $ mn 95
Table 30. Netherlands Nutrigenomics Market by Application, 2021-2031, $ mn 95
Table 31. Netherlands Nutrigenomics Market by End User, 2021-2031, $ mn 95
Table 32. Nutrigenomics Market in Rest of Europe by Country, 2021-2031, $ mn 97
Table 33. BASF SE: Company Snapshot 102
Table 34. BASF SE: Business Segmentation 103
Table 35. BASF SE: Product Portfolio 103